Report
Olivier Pauchaut

COFACE: X.Durand's first term was great, the second starts with the 25th Feb. CMD | BUY | EUR12,5(+11%)

COFACE - BUY | EUR12,5(+11%)
X.Durand's first term was great, the second starts with the 25th Feb. CMD

Very satisfactory Q4/FY performance
As expected, shareholders will be offered a 100% pay-out ratio
Four more years for Xavier Durand is the least the board can do
Buy rating maintained, waiting for the 25th Feb. CMD
Underlying
Coface SA

Coface is a holding company that performs its activities through its primary operating subsidiary, Compagnie franASSaise d'assurance pour le commerce extA(c)rieur and its subsidiaries. Through its subsidiaries, Co. is a provider of credit insurance to businesses with solutions to protect them against the rist of client insolvency on both domestic and export markets.

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Olivier Pauchaut

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch